Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Seminars in Cancer Biology|July 31, 2007
Do autochthonous tumors interfere with effector T cell responses?Thomas Blankenstein
Novartis Foundation Symposium|March 19, 2004
The role of inflammation in tumour growth and tumour suppressionThomas Blankenstein
Current Opinion in Immunology|March 16, 2005
The role of tumor stroma in the interaction between tumor and immune systemThomas Blankenstein
Nature Biotechnology|April 8, 2016
Receptor combinations hone T-cell therapyThomas Blankenstein
Nature Protocols|July 23, 2013
Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusionLiangping Li, Thomas Blankenstein
Immunological Reviews|November 6, 2007
The adaptive immune response to sporadic cancerGerald Willimsky, Thomas Blankenstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2012
Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenesKathleen Anders, Thomas Blankenstein
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cellsThomas Schüler, Thomas Blankenstein
Current Opinion in Immunology|March 14, 2003
The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesisThomas Blankenstein, Zhihai Qin
Nature Immunology|December 31, 2003
A cancer immunosurveillance controversyZhihai Qin, Thomas Blankenstein
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Seminars in Cancer Biology|July 31, 2007
Do autochthonous tumors interfere with effector T cell responses?Thomas Blankenstein
Novartis Foundation Symposium|March 19, 2004
The role of inflammation in tumour growth and tumour suppressionThomas Blankenstein
Current Opinion in Immunology|March 16, 2005
The role of tumor stroma in the interaction between tumor and immune systemThomas Blankenstein
Nature Biotechnology|April 8, 2016
Receptor combinations hone T-cell therapyThomas Blankenstein
Nature Protocols|July 23, 2013
Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusionLiangping Li, Thomas Blankenstein
Immunological Reviews|November 6, 2007
The adaptive immune response to sporadic cancerGerald Willimsky, Thomas Blankenstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2012
Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenesKathleen Anders, Thomas Blankenstein
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cellsThomas Schüler, Thomas Blankenstein
Current Opinion in Immunology|March 14, 2003
The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesisThomas Blankenstein, Zhihai Qin
Nature Immunology|December 31, 2003
A cancer immunosurveillance controversyZhihai Qin, Thomas Blankenstein
Pageof 14